Prophylaxis and therapy of diarrhea with Yomogi®

Diarrhea associated with irritable bowel syndrome (IBS)

Chronic diarrhea is a major symptom in irritable ­bowel syndrome. This is often accompanied by abdominal pain, bloating and thus also by a limitation in the quality of life.
A new double-blind study from 2014 shows: The ­active substance in Yomogi, S. ­boulardii, is also significantly effective in the treatment of diarrhea in irritable bowel syndrome.21 In this clinical trial with a total of 60 patients, 30 patients received Yomogi over 3 weeks, the other 30 patients received placebo. In addition to the reduction of diarrhea, Yomogi also reduced abdominal pain and bloating in this study. The patients reported that in this way their quality of life had significantly improved.

Significant efficacy of the study medication Yomogi in diarrhea ­associated with irritable bowel syndrome after 3-weeks of treatment21

21) Akhondi-Meybodi M, Rahimian M, Salmanroghani H, Amirbeigy M, Baghbanian M, Ghelmani SY. Study of the Effect of Probiotic Saccharomyces Boulardii on the Treatment of Irritable Bowel Syndrome. J Biol Today’s World. 2014;3(7):152–156.

Yomogi international package insert to download
Yomogi 250 mg international package insert to download